{
    "2019-04-02": [
        [
            {
                "time": "",
                "original_text": "中信建投医药】科创系列之特宝生物： 创新重组蛋白药物企业",
                "features": {
                    "keywords": [
                        "特宝生物",
                        "创新",
                        "重组蛋白",
                        "医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "德银：降上海医药(02607.HK)目标价至22.7港元 评级“买入”",
                "features": {
                    "keywords": [
                        "德银",
                        "上海医药",
                        "目标价",
                        "买入"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上海医药:工商稳健经营,研发投入力度继续加强",
                "features": {
                    "keywords": [
                        "上海医药",
                        "研发投入",
                        "稳健经营"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-02",
                "original_text": "【每日晨报】0402丨首批区块链信息服务备案落地，相关产业链迎利好",
                "features": {
                    "keywords": [
                        "区块链",
                        "信息服务",
                        "备案",
                        "利好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "区块链"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【晨会聚焦】4月资产配置观：一波三折，去伪存真",
                "features": {
                    "keywords": [
                        "资产配置",
                        "去伪存真"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-01",
                "original_text": "【医药】江琦、祝嘉琦（研究助理）：2019年4月月报-医药创新是大方向，关注Q1高增长的优质公司-20190401",
                "features": {
                    "keywords": [
                        "医药创新",
                        "优质公司",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药:研发投入同比快速增长,持续夯实全国性商业网络布局",
                "features": {
                    "keywords": [
                        "上海医药",
                        "研发投入",
                        "快速增长",
                        "商业网络"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}